Biomia
2 known investors
Find your way into Biomia
Biomia is a biotechnology company using biology, chemistry, and pharmacoengineering to develop a new generation of central nervous system (CNS) therapeutics. It focuses on drug discovery to address unmet patient needs.
Investors · 2
BlueYard Capitallisted by BlueYard CapitalBerlin · $500K – $5M
How we know: BlueYard Capital's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Nucleus Capitallisted by Nucleus CapitalBerlin · $1M – $1.1M
How we know: Nucleus Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Biomia do?
- Biomia is a biotechnology company using biology, chemistry, and pharmacoengineering to develop a new generation of central nervous system (CNS) therapeutics. It focuses on drug discovery to address unmet patient needs.
- Who are Biomia's investors?
- Biomia's investors include BlueYard Capital, Nucleus Capital.

